Analysts’ Top Healthcare Picks: Danaher (DHR), Palvella Therapeutics (PVLA)
at www.tipranks.com (Fri, 30-Jan 11:10 AM)
at www.tipranks.com (Fri, 30-Jan 11:00 AM)
Xeris Projects Record 2025 Revenues, Driven by Strong Growth in Recorlev, Gvoke, and Keveyis
Market Chameleon (Thu, 8-Jan 8:41 AM)
Xeris Biopharma Achieves Record Q3 Results as Recorlev Revenue Surges 109%—Guidance Raised for 2025
Market Chameleon (Thu, 6-Nov 7:59 AM)
